|
ACP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.030800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.543600E-02 |
| Normal-vs-Stage2 |
7.905400E-01 |
| Normal-vs-Stage3 |
7.247800E-01 |
| Normal-vs-Stage4 |
5.286000E-01 |
| Stage1-vs-Stage2 |
1.510040E-01 |
| Stage1-vs-Stage3 |
9.085800E-02 |
| Stage1-vs-Stage4 |
2.361200E-01 |
| Stage2-vs-Stage3 |
9.602000E-01 |
| Stage2-vs-Stage4 |
6.064400E-01 |
| Stage3-vs-Stage4 |
6.211800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.213200E-01 |
| Normal-vs-AfricanAmerican |
4.574800E-01 |
| Normal-vs-Asian |
8.126400E-01 |
| Caucasian-vs-AfricanAmerican |
8.479400E-01 |
| Caucasian-vs-Asian |
9.673200E-01 |
| AfricanAmerican-vs-Asian |
9.789800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.754100E-02 |
| Normal-vs-Female |
9.734400E-01 |
| Male-vs-Female |
1.635040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.632250E-01 |
| Normal-vs-Extreme_Weight |
3.435800E-02 |
| Normal-vs-Obese |
9.421000E-01 |
| Normal-vs-Extreme_Obese |
6.008400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.255600E-01 |
| Normal_Weight-vs-Obese |
2.225600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.851800E-01 |
| Extreme_Weight-vs-Obese |
7.880000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.685600E-01 |
| Obese-vs-Extreme_Obese |
5.798400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.640400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.988800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.864300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.658000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.738200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.262570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.433400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.449700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.180400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.329400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.349200E-01 |
| Normal-VS-Type2 PRCC |
2.499600E-01 |
| Normal-VS-KIRP CIMP |
1.216990E-01 |
| Normal-VS-Unclassified PRCC |
5.554800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.327800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.153620E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.038000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.484300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.456000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.666000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.276700E-03 |
| Normal-vs-N1 |
1.089600E-01 |
| Normal-vs-N2 |
5.464400E-01 |
| N0-vs-N1 |
7.877400E-03 |
| N0-vs-N2 |
1.900800E-01 |
| N1-vs-N2 |
6.502200E-01 |
|
|
